Advanced Biomedical Ownership
| ABMT Stock | USD 0.0001 0.00 0.00% |
Advanced |
Advanced Pink Sheet Ownership Analysis
The company recorded a loss per share of 0.01. Advanced Biomedical had not issued any dividends in recent years. The entity had 10:1 split on the 13th of March 2009. Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. Advanced Biomedical Technologies, Inc. was founded in 2002 and is based in New York, New York. Advanced Biomedical operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 17 people.The quote for Advanced Biomedical Technologies is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Advanced Biomedical Technologies please contact Hui Wang at 718 766 7898 or go to https://abtlafleur.com.Advanced Biomedical Outstanding Bonds
Advanced Biomedical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Advanced Biomedical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Advanced bonds can be classified according to their maturity, which is the date when Advanced Biomedical Technologies has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| AAP 59 09 MAR 26 Corp BondUS00751YAH99 | View | |
| AAP 35 15 MAR 32 Corp BondUS00751YAG17 | View | |
| US00751YAF34 Corp BondUS00751YAF34 | View | |
| US00751YAE68 Corp BondUS00751YAE68 | View | |
| AAP 595 09 MAR 28 Corp BondUS00751YAJ55 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Advanced Pink Sheet Analysis
When running Advanced Biomedical's price analysis, check to measure Advanced Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Advanced Biomedical is operating at the current time. Most of Advanced Biomedical's value examination focuses on studying past and present price action to predict the probability of Advanced Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Advanced Biomedical's price. Additionally, you may evaluate how the addition of Advanced Biomedical to your portfolios can decrease your overall portfolio volatility.